Literature DB >> 14744618

Antiemetic effect of dexamethasone on cisplatin-induced early and delayed emesis in the pigeon.

Sachiko Tanihata1, Satoko Oda, Shuzo Nakai, Toshimitsu Uchiyama.   

Abstract

We investigated the ability of dexamethasone to attenuate cisplatin (4 mg/kg, i.v.)-induced early and delayed emesis. These appear within the first 8-h period (early phase) and between 8 and 48 h (delayed phase), respectively, after cisplatin administration in the pigeon. Dexamethasone (0.1 and 1 mg/kg, i.m.) reduced significantly the number of emetic responses to cisplatin by 56% and 82% (P<0.05), respectively, in the early phase, and by 41% and 66% (P<0.05), respectively, in the delayed phase. Dexamethasone (1 and 10 microg/kg, i.c.v.) reduced the number of emetic responses by 66% and 91% (P<0.05), respectively, in the early phase, and by 56% and 87% (P<0.05), respectively, in the delayed phase. Indomethacin (10 mg/kg, i.m.) did not suppress cisplatin-induced early and delayed emesis. Dexamethasone (1 mg/kg, i.m.) did not affect the content of platinum in the medulla oblongata after cisplatin administration. The above results suggest that dexamethasone has antiemetic effects on both the early and delayed emetic responses to cisplatin in pigeons, partially via its central site of action, and that the antiemetic mechanism of dexamethasone is related to factors other than its inhibition of prostanoid synthesis or its membrane stabilizing effect which reduces influx of cisplatin into the medulla oblongata.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744618     DOI: 10.1016/j.ejphar.2003.11.033

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  A Prospective Multicenter Study Evaluating Secondary Adrenal Suppression After Antiemetic Dexamethasone Therapy in Cancer Patients Receiving Chemotherapy: A Korean South West Oncology Group Study.

Authors:  Hye Sook Han; Ji Chan Park; Suk Young Park; Kyu Taek Lee; Sang Byung Bae; Han Jo Kim; Samyoung Kim; Hwan Jung Yun; Woo Kyun Bae; Hyun-Jeong Shim; Jun-Eul Hwang; Sang-Hee Cho; Moo-Rim Park; Hyeok Shim; Jihyun Kwon; Moon Ki Choi; Seung Taik Kim; Ki Hyeong Lee
Journal:  Oncologist       Date:  2015-10-13

Review 2.  Chemotherapy-induced nausea and vomiting: optimizing prevention and management.

Authors:  Kamakshi V Rao; Aimee Faso
Journal:  Am Health Drug Benefits       Date:  2012-07

3.  Receptor-selective agonists induce emesis and Fos expression in the brain and enteric nervous system of the least shrew (Cryptotis parva).

Authors:  Andrew P Ray; Seetha Chebolu; Nissar A Darmani
Journal:  Pharmacol Biochem Behav       Date:  2009-08-21       Impact factor: 3.533

Review 4.  Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases.

Authors:  Paul L R Andrews; Charles C Horn
Journal:  Auton Neurosci       Date:  2006-03-23       Impact factor: 3.145

5.  The antiemetic interaction of Delta9-tetrahydrocannabinol when combined with tropisetron or dexamethasone in the least shrew.

Authors:  Yaozhi Wang; Andrew P Ray; Bryan A McClanahan; Nissar A Darmani
Journal:  Pharmacol Biochem Behav       Date:  2008-08-09       Impact factor: 3.533

6.  Glucocorticoid resistance of migration and gene expression in a daughter MDA-MB-231 breast tumour cell line selected for high metastatic potential.

Authors:  Ebony R Fietz; Christine R Keenan; Guillermo López-Campos; Yan Tu; Cameron N Johnstone; Trudi Harris; Alastair G Stewart
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

7.  Synthetic and natural antioxidants attenuate cisplatin-induced vomiting.

Authors:  Javaid Alam; Fazal Subhan; Ihsan Ullah; Muhammad Shahid; Gowhar Ali; Robert D E Sewell
Journal:  BMC Pharmacol Toxicol       Date:  2017-01-13       Impact factor: 2.483

8.  Differential Glucocorticoid-Dependent Regulation and Function of the ERRFI1 Gene in Triple-Negative Breast Cancer.

Authors:  Chromewell Agustin R Mojica; Weand S Ybañez; Kevin Christian V Olarte; Alyssa Beatrice C Poblete; Pia D Bagamasbad
Journal:  Endocrinology       Date:  2020-07-01       Impact factor: 4.736

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.